GSK has application to expand use of mepolizumab accepted by EMA
(Alliance News) - GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstructive pulmonary disease accepted for review by the European Medicines Agency. Read More